[Therapy of malignant pheochromocytoma. Invitation to participate in a randomized multicenter study]

MeSH terms

• 3-Iodobenzylguanidine
• Adrenal Gland Neoplasms / diagnosis
• Adrenal Gland Neoplasms / diagnostic imaging
• Adrenal Gland Neoplasms / drug therapy*
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / therapeutic use
• Antineoplastic Agents, Alkylating / administration & dosage
• Antineoplastic Agents, Hormonal / administration & dosage
• Antineoplastic Agents, Hormonal / therapeutic use
• Antineoplastic Agents, Phytogenic / administration & dosage
• Cyclophosphamide / administration & dosage
• Dacarbazine / administration & dosage
• Drug Therapy, Combination
• Humans
• Indium Radioisotopes
• Injections, Subcutaneous
• Interferon-alpha / administration & dosage
• Interferon-alpha / therapeutic use
• Iodine Radioisotopes
• Octreotide / administration & dosage
• Octreotide / therapeutic use
• Pheochromocytoma / diagnosis
• Pheochromocytoma / diagnostic imaging
• Pheochromocytoma / drug therapy*
• Placebos
• Radionuclide Imaging
• Radiopharmaceuticals
• Time Factors
• Vincristine / administration & dosage